Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-004003

Chief Operating Officer sold 42,666 shares at $14.40 ($614,390)

  • Chief Operating Officer acquired 12,666 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GIVEN BRUCE D · Chief Operating Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-14 Exercise or conversion : show line 1 in the form +11,666 $2.62 $30,565 1,110,022 D
2019-01-14 Exercise or conversion : show line 2 in the form +1,000 $6.20 $6,200 1,111,022 D
2019-01-14 Sale : show line 3 in the form −42,666 $14.40 $614,390 1,068,356 D
Open-market sales · 42,666 sh · avg $14.40 · $614,390

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-01-14 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −11,666 544,334 D
2019-01-14 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −1,000 543,334 D
Loading xslF345X03/doc4.xml…